Dan + Shay! Doja Cat! Glass Animals! Inside PEOPLE's Billboard Music Awards 2022 Photo Booth

Sarah Michaud

The annual awards show was held Sunday, May 15 at the MGM Grand Garden Arena in Las Vegas

  • Up next
  • Up next
  • Up next
  • Up next

Latest Stories

  • Bank of Montreal's Dividend Analysis

    Bank of Montreal (NYSE:BMO) recently announced a dividend of $1.51 per share, payable on 2024-05-28, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Bank of Montreal's dividend performance and assess its sustainability.

  • Petroleo Brasileiro SA Petrobras's Dividend Analysis

    Petroleo Brasileiro SA Petrobras (NYSE:PBR) recently announced a dividend of $0.42 per share, payable on an unconfirmed future date, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Petroleo Brasileiro SA Petrobras's dividend performance and assess its sustainability.

  • Munchener Ruckversicherungs-Gesellschaft AG's Dividend Analysis

    Munchener Ruckversicherungs-Gesellschaft AG (MURGY) recently announced a dividend of $1.61 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Munchener Ruckversicherungs-Gesellschaft AG's dividend performance and assess its sustainability.

  • Blackstone Inc's Dividend Analysis

    Blackstone Inc (NYSE:BX) recently announced a dividend of $0.83 per share, payable on 2024-05-06, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Blackstone Inc's dividend performance and assess its sustainability.

  • Mama's Creations Inc (MAMA) (Q4 2024) Earnings Call Transcript Highlights: Robust Growth and ...

    Discover how Mama's Creations Inc achieved significant revenue and profit increases, and their strategic moves for future growth.

  • Q1 2024 Chipotle Mexican Grill Inc Earnings Call

    Q1 2024 Chipotle Mexican Grill Inc Earnings Call

  • Q1 2024 Century Communities Inc Earnings Call

    Q1 2024 Century Communities Inc Earnings Call

  • Priest mode activated: Secluded Welsh monastery for sale for £1.5 million

    Looking to live like a hermit? Capel-Y-Ffin Monastery might be the place to do it

  • Bubbledogs returns: cult Champagne and hotdog restaurant to make triumphant return at 45 Park Lane

    The much-missed restaurant will become a summer-long pop-up on Park Lane

  • Nasdaq's revenue beats on strong demand for fintech products

    Nasdaq beat estimates for first-quarter revenue on Thursday, driven by strong demand for its financial technology products used by traders and investors to navigate the capital markets. Revenue from its financial technology unit surged 71% to $392 million in the first quarter, while revenue from its index business jumped 53% to $168 million. Nasdaq, like its peers, has been on an acquisition spree to diversify its portfolio of technology and intellectual property after regulations in 2005 opened the equities trading market up to competition from brokers.

  • Decades-old Premium Bonds fail to win any prize

    Thousands of Premium Bond holders who opened their accounts more than two decades ago have not yet won a prize, Telegraph analysis has found.

  • Is it time to sell the Magnificent Seven?

    Only a few weeks ago, a key question for investors was: “have I still got time to buy into the Magnificent Seven?”

  • Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth

    Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop and commercialize gene editing therapies for multiple diseases, the companies said on Thursday. Mammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to create disease-modifying medicines that can be delivered to tissues beyond the liver. CRISPR, discovered by Jennifer Doudna and CRISPR Therapeutics co-founder Emmanuelle Charpentier, uses molecular "scissors" to trim faulty parts of genes that can then be disabled or replaced with new strands of normal DNA.

  • Congress Sends Biden a Bill That Could Ban TikTok

    Included within Congress' $95 billion national security package is a provision that could lead to TikTok being banned in America. However, the ban would take place after the 2024 election, NBC News reports.

  • Affordable housing fueled heated Johnson County city election. Where do plans stand now?

    A housing debate escalated into an intense political battle in this Johnson County city.

  • TelevisaUnivision Posts 1Q Loss But Projects Streaming Profits in 2H

    Continued investment in streaming contributed to a first-quarter loss for Spanish-language media giant TelevisaUnivision, which is seeing the bulk of its growth come from its Mexican operations while U.S. revenue stays flat with year-earlier results. The company, which operates the Univision TV network, said operating expenses grew 16% during the first quarter, to $821 million, …

  • Crumbling school buildings, a proposed tax increase — What’s at stake in KCKPS bond vote?

    A $420 million plan would rebuild public schools in Kansas City, Kansas. Will voters support it?

  • Welcome to Otto's: Is this London's maddest restaurant — or its most magical?

    It’s the critics’ cult favourite — but what is Otto’s really like? First-timer Joanna Taylor and regular David Ellis go for the feast of their lives

  • Bristol Myers posts quarterly loss, revenue rises 5%

    Bristol Myers Squibb on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio and Mirati Therapeutics offset a 5% increase in revenue. The New Jersey-based drugmaker posted a loss of $4.40 per share, including charges for acquired research and development. On a net basis, Bristol's loss was $5.89 per share.

  • Harley-Davidson quarterly profit falls on slow demand

    Despite Harley's attempt to spruce up its offerings with electric options, the 120-year-old motorcycle maker has not been highly successful in attracting millennials, forcing it to rely on its tried-and-tested customer base of boomers to drive sales. Global motorcycle shipments, including those of Cruiser, Trike and Touring bikes, fell 7% in the quarter from a year earlier. Revenue fell 5% to $1.48 billion, driven by a decrease in wholesale shipments and lower global pricing.